These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3774259)
1. Enterohepatic circulation and distribution of 131I-6 beta-iodomethyl-19-norcholesterol (NP-59). Lynn MD; Gross MD; Shapiro B Nucl Med Commun; 1986 Aug; 7(8):625-30. PubMed ID: 3774259 [TBL] [Abstract][Full Text] [Related]
2. The influence of hypercholesterolaemia on the adrenal uptake and metabolic handling of 131I-6 beta-iodomethyl-19-norcholesterol (NP-59). Lynn MD; Gross MD; Shapiro B; Bassett D Nucl Med Commun; 1986 Aug; 7(8):631-7. PubMed ID: 3774260 [TBL] [Abstract][Full Text] [Related]
3. Value of bowel preparation in adrenocortical scintigraphy with NP-59. Shapiro B; Nakajo M; Gross MD; Freitas J; Copp J; Beierwaltes WH J Nucl Med; 1983 Aug; 24(8):732-4. PubMed ID: 6875684 [TBL] [Abstract][Full Text] [Related]
4. [Effects of specific radioactivities and cholagogues on tissue distribution of 131I-6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-131I) in rats]. Ito T; Ogawa H; Maeda M; Kojima M Yakugaku Zasshi; 1983 Jun; 103(6):644-9. PubMed ID: 6655551 [No Abstract] [Full Text] [Related]
5. The relationship of I-131 6 beta-iodomethyl-19-norcholesterol (NP-59) adrenal cortical uptake to indices of androgen secretion in women with hyperandrogenism. Gross MD; Shapiro B; Freitas JE; Ayers J; Swanson DP; Woodbury MC; Schteingart DE; Beierwaltes WH Clin Nucl Med; 1984 May; 9(5):264-70. PubMed ID: 6235079 [TBL] [Abstract][Full Text] [Related]
6. [Adrenal scintigraphy with 131I-6beta-iodomethyl-19-norcholesterol: good practice guideline]. Bardet S; Nocaudie-Calzada M; Kraimps JL; Tabarin A; Wémeau JL Ann Endocrinol (Paris); 1998 Nov; 59(4):344-53. PubMed ID: 9864556 [TBL] [Abstract][Full Text] [Related]
7. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)]. Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324 [No Abstract] [Full Text] [Related]
8. Distinguishing benign from malignant euadrenal masses. Gross MD; Shapiro B; Bouffard JA; Glazer GM; Francis IR; Wilton GP; Khafagi F; Sonda LP Ann Intern Med; 1988 Oct; 109(8):613-8. PubMed ID: 3421574 [TBL] [Abstract][Full Text] [Related]
9. Positive iodine-131 6 beta-iodomethyl-19-norcholesterol (NP-59) adrenal images can precede return of adrenocortical function after o,p' DDD treatment. Sparagana M; Ackerman L Clin Nucl Med; 1988 May; 13(5):348-51. PubMed ID: 3390980 [TBL] [Abstract][Full Text] [Related]
10. Case report: failure of adrenal scintigraphy to exhibit 131I cholesterol uptake in a CT-demonstrated, surgically proven aldosteronoma. Salam Z; Lubbos H; Martinez C; Mozley PD; Miller JL; Rose LI Am J Med Sci; 1996 Sep; 312(3):130-2. PubMed ID: 8783680 [TBL] [Abstract][Full Text] [Related]
11. Imaging the adrenal cortex: why and wherefore? Britton KE Nucl Med Commun; 1992 Jul; 13(7):485-7. PubMed ID: 1495676 [No Abstract] [Full Text] [Related]
12. 3-Ethyl and 3-methyl ethers of 19-iodocholesterol as potential adrenal scanning agents. Owoyale JA; Szinai SS Steroids; 1981 Feb; 37(2):133-41. PubMed ID: 7013159 [TBL] [Abstract][Full Text] [Related]
14. Adrenocortical scintigraphy with 131I-6-beta-iodomethyl-norcholesterol (NP 59) in bilateral adrenocortical carcinoma. Ruíz Hernández G; Pallarés FJ; Bartual AR; Tenes Rodrigo S; Ampudia-Blasco FJ; de Avila y Avalos CR Nuklearmedizin; 1998 Jun; 37(4):141-5. PubMed ID: 9650214 [TBL] [Abstract][Full Text] [Related]
15. A new and superior adrenal scanning agent, NP-59. Sarkar SD; Beierwaltes H; Ice RD; Basmadjian GP; Hetzel KR; Kennedy WP; Mason MM J Nucl Med; 1975 Nov; 16(11):1038-42. PubMed ID: 1185265 [TBL] [Abstract][Full Text] [Related]
16. SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma. La Cava G; Imperiale A; Olianti C; Gheri GR; Ladu C; Mannelli M; Pupi A J Nucl Med; 2003 Jul; 44(7):1057-64. PubMed ID: 12843220 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan. Wu MH; Liu FH; Lin KJ; Sun JH; Chen ST Nucl Med Commun; 2019 Jun; 40(6):568-575. PubMed ID: 30694876 [TBL] [Abstract][Full Text] [Related]
18. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome. Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105 [TBL] [Abstract][Full Text] [Related]